vimarsana.com

GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market

Card image cap

May 17, 2024 - GeoVax Labs, Inc. , a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into a...

Related Keywords

Japan , , Geovax Labs Inc , Exchange Commission , Nasdaq , Roth Capital Partners , Company Contact , Vax Labs , Capital Partners , Clemente Drive , Investor Relations Contact , Media Contact , Japan Corporate News ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.